BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10227349)

  • 1. HDR brachytherapy makes Cs-137 intracavitary therapy for cervix cancer a breach of good practice.
    Gillin MT; Palta JR
    Med Phys; 1999 Apr; 26(4):499-501. PubMed ID: 10227349
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase III randomized trial comparing LDR and HDR brachytherapy in treatment of cervical carcinoma.
    Lertsanguansinchai P; Lertbutsayanukul C; Shotelersuk K; Khorprasert C; Rojpornpradit P; Chottetanaprasith T; Srisuthep A; Suriyapee S; Jumpangern C; Tresukosol D; Charoonsantikul C
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1424-31. PubMed ID: 15275728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective study of HDR (192Ir) versus MDR (137Cs) intracavitary brachytherapy for carcinoma of the uterine cervix.
    Tanaka E; Oh RJ; Yamada Y; Shiomi H; Nakamura S; Shimamoto S; Teshima T; Inoue T; Inoue T
    Brachytherapy; 2003; 2(2):85-90. PubMed ID: 15062145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conversion from Cs-137 to Ir-192 for high dose rate remote afterloading: practical considerations.
    Bellotti JE; Kagan AR; Olch A; Wollin M
    Med Phys; 1992; 19(2):377-83. PubMed ID: 1584136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low morbidity following 9,000-rad intracavitary endocurietherapy (ECT) using the Kumar Cervical Applicator and external-beam radiotherapy (EXRT) in the management of carcinoma of the uterine cervix.
    Kumar PP; Good RR; Scott JC; Jones EO; Lynch G; McCaul GF
    Radiat Med; 1988; 6(2):92-106. PubMed ID: 3140299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetry comparison between interstitial and intracavitary irradiation in the treatment of uterine cervix cancer.
    Kumar PP; Good RR; Jones EO
    Radiat Med; 1986; 4(3):89-96. PubMed ID: 3104997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lurleen B. Wallace cervical-uterine applicator. Intracavitary treatment of cancer of the uterine cervix.
    Kim RY; Black NC; Salter MM
    Ala J Med Sci; 1988 Jul; 25(3):288-90. PubMed ID: 3177802
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment experiences with intracavitary 137Cs after-loading in a five-year patient material with uterine-cervical carcinoma.
    Csömör S; Vigváry Z; Szanyi L
    Acta Chir Hung; 1991; 32(2):119-26. PubMed ID: 1819882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Afterloading intracavitary irradiation therapy for cancer of uterine cervix].
    Lou HK
    Zhonghua Fu Chan Ke Za Zhi; 1993 Nov; 28(11):649-50, 699. PubMed ID: 8313729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dosimetric provisions for intracavitary gamma therapy of cancer of the cervix on the "Curietron" afterloading apparatus].
    Khangel'dian AG; Makhmurian TD; Zakharian IU; Fadeeva MA; Klepper LL
    Med Radiol (Mosk); 1983 Jan; 28(1):29-32. PubMed ID: 6827929
    [No Abstract]   [Full Text] [Related]  

  • 11. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study.
    Erickson B; Eifel P; Moughan J; Rownd J; Iarocci T; Owen J
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1083-92. PubMed ID: 16099599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical optimization of afterloading techniques.
    Anderson LL
    Strahlentherapie; 1985 May; 161(5):264-9. PubMed ID: 4002251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five years hospital experience with the Amersham caesium 137 manual afterloading system.
    Bateman TJ; Davy TJ; Skeggs DB
    Br J Radiol; 1983 Jun; 56(666):401-7. PubMed ID: 6850227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The trail of the development of high-dose-rate brachytherapy for cervical cancer in Japan.
    Inoue T
    Jpn J Clin Oncol; 2003 Jul; 33(7):327-30. PubMed ID: 12949057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Remote afterloading system for intracavitary irradiation with low dosage of 137 cs for the treatment of cervical cancer].
    Ogawa F; Murakami K; Saeki Y; Hayashi S; Nishiguchi H
    Rinsho Hoshasen; 1975 Mar; 20(3):225-32. PubMed ID: 1168759
    [No Abstract]   [Full Text] [Related]  

  • 16. Quality assurance in the prospective multi-institutional trial on definitive radiotherapy using high-dose-rate intracavitary brachytherapy for uterine cervical cancer: the individual case review.
    Toita T; Oguchi M; Ohno T; Kato S; Niibe Y; Kodaira T; Kazumoto T; Kataoka M; Shikama N; Kenjo M; Teshima T; Kagami Y
    Jpn J Clin Oncol; 2009 Dec; 39(12):813-9. PubMed ID: 19815538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fever complicating brachytherapy application in patients with cancer of the cervix.
    Ampil FL
    Radiat Med; 1999; 17(1):59-61. PubMed ID: 10378653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accurate and economical intracavitary endocurietherapy in the treatment of uterine cervix cancer.
    Kumar PP; Good RR
    Strahlenther Onkol; 1986 Jan; 162(1):8-12. PubMed ID: 3945922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Optimization of dose distribution in combined irradiation of uterine cervix cancer with gamma-ray cesium-137 and X-9 MeV].
    Lewocki M
    Ann Acad Med Stetin; 1996; 42():199-222. PubMed ID: 9199121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Outcome and complications of treatment by intracavitary afterloading radiotherapy in 143 patients with cervical cancer].
    Ma DM
    Zhonghua Fu Chan Ke Za Zhi; 1993 Nov; 28(11):646-8, 699. PubMed ID: 8313728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.